𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potentiation of radiation-induced regrowth delay by isosorbide dinitrate in FSaII murine tumors

✍ Scribed by Bénédicte F. Jordan; Nelson Beghein; Marianne Aubry; Vincent Grégoire; Bernard Gallez


Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
74 KB
Volume
103
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Oxygen deficiency in tumors reduces the efficacy of nonsurgical treatment modalities such as conventional radiotherapy and chemotherapy. Since tumor perfusion is directly affected by the vascular resistance to flow of vessels feeding the tumor, vasodilator drugs might be a way to increase tumor blood flow and oxygenation. The effects of nitric oxide (NO) donor administration on tumor oxygenation, perfusion and radiation sensitivity were studied in the FSaII tumor model. Local tumor oxygenation was measured using electron paramagnetic resonance oximetry and a fiberoptic probe, OxyLite. We concomitantly measured the modulation of tumor blood flow by laser Doppler flowmetry. We determined FSaII tumor regrowth delay after isosorbide dinitrate administration and irradiation compared to carbogen breathing before irradiation and with X‐rays alone. Administration of the NO donor improved the FSaII tumor pO~2~ concomitant with an increase in tumor blood flow. We also demonstrated an increase in FSaII tumor radiation sensitivity after isosorbide dinitrate administration, which was similar to the effect of carbogen breathing in the same tumor model. Administration of isosorbide dinitrate could be considered in terms of improvement in tumor blood flow and a possible concomitant increase in accessibility of chemosensitizing agents to the tumor, particularly in terms of modification of the tumor response to irradiation. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Enhancement of radiation-induced regrowt
✍ Marion A. Joschko; Lorraine K. Webster; Janice Groves; Kally Yuen; Manuela Palat 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

Gemcitabine, a cytidine nucleoside analogue, has schedule-dependent antitumor activity in vitro and in vivo. Gemcitabine also has dose-and time-dependent radiosensitization properties in vitro. Thus it may have therapeutic application in combination with radiation. The aims of this study were to inv